(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid

C74H100N8O4 — CID 516322

IUPAC(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid
SMILESCCc1cc(CCc2ccccc2)n(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1.CCc1cc(CCc2ccccc2)nn1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1
InChIInChI=1S/2C37H50N4O2/c1-2-33-24-32(19-18-28-12-6-3-7-13-28)38-41(33)34-20-22-39(23-21-34)25-31-26-40(27-35(31)29-14-8-4-9-15-29)36(37(42)43)30-16-10-5-11-17-30;1-2-32-24-34(19-18-28-12-6-3-7-13-28)41(38-32)33-20-22-39(23-21-33)25-31-26-40(27-35(31)29-14-8-4-9-15-29)36(37(42)43)30-16-10-5-11-17-30/h3-4,6-9,12-15,24,30-31,34-36H,2,5,10-11,16-23,25-27H2,1H3,(H,42,43);3-4,6-9,12-15,24,30-31,33,35-36H,2,5,10-11,16-23,25-27H2,1H3,(H,42,43)/t2*31-,35+,36+/m00/s1
InChIKeyZMIBHKUKCCQFCM-CVWOWUKLSA-N
MW1165.67 g/mol
LogP13.23
Rot. Bonds22

About (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid

(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid (PubChem CID 516322) has the molecular formula C74H100N8O4 and a molecular weight of 1165.67 g/mol. Its IUPAC name is (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid.

Molecular Properties

Compound Name(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid
PubChem CID516322
Molecular FormulaC74H100N8O4
Molecular Weight1165.67 g/mol
Exact Mass1164.79
IUPAC Name(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid
SMILESCCc1cc(CCc2ccccc2)n(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1.CCc1cc(CCc2ccccc2)nn1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1
InChIInChI=1S/2C37H50N4O2/c1-2-33-24-32(19-18-28-12-6-3-7-13-28)38-41(33)34-20-22-39(23-21-34)25-31-26-40(27-35(31)29-14-8-4-9-15-29)36(37(42)43)30-16-10-5-11-17-30;1-2-32-24-34(19-18-28-12-6-3-7-13-28)41(38-32)33-20-22-39(23-21-33)25-31-26-40(27-35(31)29-14-8-4-9-15-29)36(37(42)43)30-16-10-5-11-17-30/h3-4,6-9,12-15,24,30-31,34-36H,2,5,10-11,16-23,25-27H2,1H3,(H,42,43);3-4,6-9,12-15,24,30-31,33,35-36H,2,5,10-11,16-23,25-27H2,1H3,(H,42,43)/t2*31-,35+,36+/m00/s1
InChIKeyZMIBHKUKCCQFCM-CVWOWUKLSA-N
XLogP13.23
TPSA123.20 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds22
Heavy Atoms86
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001165.67
LogP ≤ 513.23
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Analyze (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid?
The IUPAC name of (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid (CID 516322) is (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid.
What is the SMILES notation for (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid?
The canonical SMILES for (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid is CCc1cc(CCc2ccccc2)n(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1.CCc1cc(CCc2ccccc2)nn1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.
What is the InChIKey of (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid?
The InChIKey is ZMIBHKUKCCQFCM-CVWOWUKLSA-N. The full InChI is InChI=1S/2C37H50N4O2/c1-2-33-24-32(19-18-28-12-6-3-7-13-28)38-41(33)34-20-22-39(23-21-34)25-31-26-40(27-35(31)29-14-8-4-9-15-29)36(37(42)43)30-16-10-5-11-17-30;1-2-32-24-34(19-18-28-12-6-3-7-13-28)41(38-32)33-20-22-39(23-21-33)25-31-26-40(27-35(31)29-14-8-4-9-15-29)36(37(42)43)30-16-10-5-11-17-30/h3-4,6-9,12-15,24,30-31,34-36H,2,5,10-11,16-23,25-27H2,1H3,(H,42,43);3-4,6-9,12-15,24,30-31,33,35-36H,2,5,10-11,16-23,25-27H2,1H3,(H,42,43)/t2*31-,35+,36+/m00/s1.
What are the key properties of (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid?
(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid has a molecular weight of 1165.67 g/mol, XLogP of 13.23, 22 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-ethyl-5-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[5-ethyl-3-(2-phenylethyl)pyrazol-1-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid is sourced from PubChem (CID 516322), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).